Effect of Dash Diet and Acupuncture on Hypertention in Postmenopausal Women

August 22, 2023 updated by: Alaa Nabil Elsayed Mohamed, Cairo University
A study of effect of dash diet and acupuncture on hypertension in postmenopausal women

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

45 of post menopausal women divided into three groups A,B,C

  • Group (A): It will include 15 post-menopausal women who will be treated by DASH diet and anti-hypertensive drugs.
  • Group (B): It will include 15 post-menopausal women who will be treated by acupuncture and anti-hypertensive drugs.
  • Group (C): It will include 15 post-menopausal women who will be treated by DASH diet, acupuncture and anti-hypertensive drugs.

Study Type

Interventional

Enrollment (Actual)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
    • Elsharqia
      • Abu hammad, Elsharqia, Egypt, 44661
        • Alaa Nabil Elsayed Mohamed

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Their body mass index will be ranged from 25 -29.9 kg/m2
  • All patients will be medically stable when attending the study.
  • The DASH eating plan of 1800 kcal per day will be used in the study.

Exclusion Criteria:

  • Auditory and visual problems.
  • Chronic renal failure.
  • Myocardial infarction or arrythmias with heart failure.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: effect of dash diet and acupuncture on hypertention in post menopausal women
  • Group (A): It will include 15 post-menopausal women who will be treated by DASH diet and anti-hypertensive drugs.
  • Group (B): It will include 15 post-menopausal women who will be treated by acupuncture and anti-hypertensive drugs.
  • Group (C): It will include 15 post-menopausal women who will be treated by DASH diet, acupuncture and anti-hypertensive drugs.
Behavioral: dash diet
  • Group (A): It will include 15 post-menopausal women who will be treated by DASH diet and anti-hypertensive drugs.
  • Group (B): It will include 15 post-menopausal women who will be treated by acupuncture and anti-hypertensive drugs.
  • Group (C): It will include 15 post-menopausal women who will be treated by DASH diet, acupuncture and anti-hypertensive drugs.
Device: Acupuncture
acupuncture

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
blood pressure
Time Frame: 3 months
it will be measured by sphygmomanometer pre and post treatment
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
sodium and potassium levels
Time Frame: 3 months
it will be measured by blood analysis pre and post treatment
3 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
assessment of quality of life
Time Frame: 3 months
it will be measured by sf 36 questionnaire pre and post treatment
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cairo University

Collaborators

faculty of physical therapy

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 5, 2022

Primary Completion (Actual)

April 25, 2023

Study Completion (Actual)

August 20, 2023

Study Registration Dates

First Submitted

February 10, 2023

First Submitted That Met QC Criteria

August 22, 2023

First Posted (Actual)

August 29, 2023

Study Record Updates

Last Update Posted (Actual)

August 29, 2023

Last Update Submitted That Met QC Criteria

August 22, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • P.T.REC/012/003872

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postmenopausal Disorder

Clinical Trials on dash diet

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe